During the past decade, Institutul de Urgenta pentru Boli conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul de Urgenta pentru Boli" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institutul de Urgenta pentru Boli" are "Pulmonary Arterial Hypertension" (2 trials), "Acute Peripheral Arterial Occlusion" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Institutul de Urgenta pentru Boli" in a lesser frequency.

Most popular intervention types in "Institutul de Urgenta pentru Boli" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Beraprost Sodium Modified Release" (2 trials), "Empagliflozin" (2 trials), "Evolocumab" (1 trials) and "Plasmin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institutul de Urgenta pentru Boli" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Institutul de Urgenta pentru Boli". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Institutul de Urgenta pentru Boli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institutul de Urgenta pentru Boli, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Institutul de Urgenta pentru Boli has several departments that took part in Clinical trials: "Institutul de Urgenta pentru Boli Cardiovasculare "Prof. Dr. C.C. Iliescu", Sos. Fundeni nr. 258" - 4 trials